Didn't the PR also state that the Brilacidin P2b tial would enroll shortly? Since a recently as last week Leo maintained that trial start was still before end of January, I take today's PR as confirming the trial as on schedule.
The board once again is exhibiting irrational pessimism in the face of yet another trial that will lead to a billion dollar deal. It's what I said a few months ago, a few weeks ago and confirmed in this PR today.
News 
Market Data 
Discover 
